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We report the first description of a new integron containing blaVIM-2, a metallo-β-lactamase gene
from Enterobacter cloacae KU680, which was isolated from peritoneal fluid of a liver cirrhosis
patient in South Korea. Antibiotic susceptibility testing, and modified Hodge and EDTA-disc
synergy tests, were carried out to screen for metallo-β-lactamase-producing strains. PCR and
sequence analysis were used to identify and analyse the blaVIM-2-containing integron. The isolate
was resistant to most β-lactams, including imipenem, and demonstrated a positive modified
Hodge and EDTA-disc synergy test, which are findings suggesting a metallo-β-lactamase. Pre-
liminary PCR-based experiments detected the metallo-β-lactamase gene blaVIM-2. Sequencing of
the 4392 bp cloned PCR amplicon, containing the gene cassette blaVIM-2, revealed the structure of
the class 1 integron. The integron also contained additional insert gene cassettes, aadA, and
unknown open reading frames ‘orfII’ and ‘orfIII’. To the best of our knowledge, this is the first
time that this metallo-β-lactamase gene has been detected in E. cloacae.
Introduction
Enterobacter cloacae is a well-recognized nosocomial patho-
gen that causes significant infections. This microorganism is
intrinsically resistant to ampicillin and narrow-spectrum
cephalosporins, due to a chromosomal cephalosporinase.
Additional resistance to broad-spectrum cephalosporins and
aztreonam is usually related to the mutational over production
of the species-specific cephalosporinase, or production of
plasmid-mediated extended-spectrum β-lactamases. But imi-
penem-resistant clinical isolates of E. cloacae are unusual
and have been described in strains with porin alterations
combined with hyperproduction of chromosomal cepha-
losporinase, and in strains producing class A carbapenem-
hydrolysing non-metallo-β-lactamases, such as NmcA
β-lactamase and IMI-1 β-lactamase.1
However, class B metallo-β-lactamases have been
reported recently in several strains of Gram-negative bacilli.2
These enzymes possess the broadest substrate hydrolysis
range among β-lactamases of Gram-negative bacilli, includ-
ing penicillins, cephalosporins, cephamycins and carba-
penems, but not monobactams. Since the first finding of IMP-
1 metallo-β-lactamase in a clinical isolate of Pseudomonas
aeruginosa in Japan in 1988, IMP-2, VIM-1 and VIM-2
metallo-β-lactamases have been reported in various Gram-
negative bacilli. The blaVIM and blaIMP genes occur in mobile
gene cassettes inserted in the variable regions of integrons.3
Gene cassettes are mobile elements, so that horizontal spread
of resistance can be anticipated, in addition to clonal spread.
In 2000, an imipenem-resistant strain of E. cloacae was
isolated in a tertiary care hospital in Busan, Korea, from the
peritoneal fluid of a patient with liver cirrhosis, which carried
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a blaVIM-2-containing integron. To the best of our knowledge,
E. cloacae strains carrying metallo-β-lactamase genes have
not been reported before. Therefore, we undertook this study
to analyse the structure of the blaVIM-2-containing integron.
Materials and methods
Bacterial strains and susceptibility testing
The E. cloacae KU680 isolate was identified by the conven-
tional method, and with the API 20E system (bioMérieux
Vitek, Marcy-l’Étoile, France). Antibiotic-containing discs
(BBL, Cockeysville, MD, USA) were used for routine anti-
biograms by disc diffusion assay.4 MICs of antimicrobial
agents were determined by the agar dilution method.5
Escherichia coli ATCC 25922 was used as MIC reference
strain. Modified Hodge and EDTA-disc synergy tests were
performed for the screening of metallo-β-lactamase-produc-
ing strains.6
Conjugation and isoelectric focusing of β-lactamase
The filter mating method was used to determine the transfer-
ability of the carbapenem resistance determinant, as previ-
ously described.7 The isoelectric points of β-lactamases were
determined by loading cell sonicates to precast pH 3 to 10
gels. The gel was overlaid with a filter paper soaked in 20 mM
EDTA for 5 min, before the imipenem (0.5 mg/L)-containing
Mueller–Hinton agar was added. In this manner, inhibition of
imipenem-hydrolysing activities could be observed.
Molecular techniques
Searches for blaIMP-1 and blaVIM-2 genes in E. cloacae KU680
were performed by PCR amplification with the following sets
of primers: for the blaIMP-1 gene, IMP-1F (5′-CATGGTTT-
GGTGGTTCTTGT-3′) and IMP-1R (5′-ATAATTTGGCG-
GACTTTGGC-3′); for the blaVIM-2 gene, VIM-2F (5′-ATG-
TTCAAACTTTTGAGTAAG-3′) and VIM-2R (5′-CTACT-
CAACGACTGAGCG-3′); for the class 1 integron, 5′CS-F
(5′-CTTCTAGAAAACCGAGGATGC-3′) and 3′CS-R
(5′-CTCTCAAGATTTTAATGCGGATG-3′). PCR ampli-
fication was carried out as previously described,7 as was the
preparation of recombinant plasmids containing PCR prod-
uct, and transformation of them into E. coli DH5α.7 Plasmids
from successful clones were used to determine the sequence
of the integron by the dideoxynucleotide-chain termination
method, with an automatic DNA sequencer (ABI 3700,
Perkin-Elmer, Foster City, CA, USA). The determination of
the sequence was repeated with more than two clones from
independent amplicons. Both strands were sequenced.
Nucleotide and amino acid sequence analysis
Nucleotide sequence analysis was performed with DNASIS
for Windows (Hitachi Software Engineering America Ltd,
San Bruno, CA, USA). Database similarity searches for
nucleotide and deduced amino acid sequences were carried
out at the NCBI website (http://www.ncbi.nlm.nih.gov).
Nucleotide sequence accession number
The nucleotide sequences of the blaVIM-2 gene of E. cloacae
KU680 have been assigned to the GenBank nucleotide
sequence database under accession number AF305559.
Results
Properties of E. cloacae KU680
Disc diffusion testing revealed that E. cloacae KU680 isol-
ate was resistant to most β-lactams, including ampicillin,
ampicillin–sulbactam, piperacillin, piperacillin–tazobactam,
cefalothin, cefoxitin, cefotaxime, ceftazidime and aztreonam.
The isolate was also resistant to tobramycin, intermediate to
gentamicin, but susceptible to amikacin and ciprofloxacin.
MICs of imipenem and meropenem for the isolate were
4 mg/L, and that of aztreonam was 64 mg/L. MICs of
ampicillin, ampicillin–sulbactam, piperacillin, piperacillin–
tazobactam, cefalothin, cefoxitin, cefotaxime and ceftaz-
idime were >128 mg/L.
Isoelectric focusing of extract of the isolate showed two
β-lactamase bands of pI ∼5.3 and 9.0. The isolate showed
positive modified Hodge and EDTA-disc synergy tests, and
the only pI 5.3 band was no longer present when the gels
were overlaid with EDTA, which are findings suggesting a
metallo-β-lactamase. The band of pI ∼9.0 was likely to be
chromosomal AmpC cephalosporinase. Carbapenem resist-
ance was not transferred by conjugation. A plasmid harbour-
ing a carbapenem resistance determinant was not detected
(data not shown). These results suggest that a metallo-β-
lactamase gene may be located on the chromosome.
Sequence analysis of the blaVIM-2-containing integron
Preliminary PCR-based experiments detected blaVIM-2 but
failed to detect blaIMP-1. Sequence analysis of the 4392 bp
cloned PCR amplicon revealed the structure of the class 1
integron, such as the 5′-CS element containing an IntI1 inte-
grase gene with its own promotor region, an attI1 recombina-
tion site, and the 3′-CS element containing qacE∆1. The
integron contained insert gene cassettes blaVIM-2, aadA1, and
unknown open reading frames (ORFs) ‘orfII’ and ‘orfIII’.
The blaVIM-2 gene was located immediately downstream of the
IntI1 integrase gene. The initiation codon of the blaVIM-2 gene
was proceeded by a putative promoter region of Pc. The
guanine at the second base in the –35 consensus of the pro-
moter Pc was replaced by thymidine, and the guanine at the
fourth base in the –10 consensus was replaced by adenine.
The blaVIM-2 gene cassettes had a 59 bp element, and the
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qacE∆1 gene also had a core site at its 5′ end. The sequences
of orfII and orfIII did not show a typical cassette structure, i.e.
possession of the consensus core sequence of GTTRRRY on
the 5′ end (Figure 1).
Discussion
Since 1989, metallo-β-lactamases have spread among
glucose non-fermenting Gram-negative bacilli, including
Pseudomonas aeruginosa, Pseudomonas putida, Alcaligenes
(Achlomobacter) xylosoxidans, Acinetobacter baumannii
and Acinetobacter genomospecies 3.7,8 However, these
enzymes were rarely found in members of the family Entero-
bacteriaceae. The presence of the mobile blaVIM-2-containing
integron in E. cloacae suggests that the resistance can spread
to other members of the family Enterobacteriaceae.
MICs of imipenem (4 mg/L) and meropenem (4 mg/L) for
E. cloacae KU680 were relatively low compared with those
for VIM-2-producing P. aeruginosa COL-1 (128 mg/L) and
Serratia marcescens YMC 00/4/1591 (64 mg/L).8,9 The dif-
ference in permeability coefficients of carbapenems between
bacterial species may play a role in the low level of resistance
to carbapenems.10
The Pc promoter for the blaVIM-2 gene is a strong promoter,
due to the point mutations in the –35 and –10 consensus
regions.9 The P2 promoter was not found upstream of the
blaVIM-2 gene. P2 expression may be responsible for up to 90%
of blaVIM-2 transcription, as described for other integron-
located genes.9 Inactive P2 promoter may also play a role in
the low expression of resistance to carbapenems.
VIM-2 metallo-β-lactamase has no hydrolytic activity
against aztreonam, but the MIC of aztreonam for E. cloacae
KU680 was 64 mg/L, which is higher than the resistant break-
point.9 This result was possibly due to production of a
chromosomal cephalosporinase (pI ∼9.0). The isolate was
found to be resistant to tobramycin and intermediate to genta-
micin, but the new class 1 integron in this study contained
only a streptomycin/spectinomycin adenyltransferase gene
(aadA1) besides blaVIM-2 cassettes, suggesting that the gene(s)
responsible for the aminoglycoside resistance resided in
another location.
The structure of the new integron (intI1 [blaVIM-2 aadA1
orfII orfIII] qacE∆1) was similar to that of an integron in
P. putida YMC 97/8/322 (intI1 [blaVIM-2 aacA7 aadA1]
qacE∆1; GenBank accession number AF327064), that of an
integron in Acinetobacter genomospecies 3 YMC 99/11/160
(intI1 [blaVIM-2 aacA4 aadA1 orfII orfIII] qacE∆1; GenBank
accession number AF369871), and that of an integron in
P. aeruginosa YMC 95/1/704 (intI1 [aacA4 blaVIM-2 orfI
aadA1 orfII orfIII] qacE∆1; GenBank accession number
AY029772), all of which were detected in South Korea. The
nucleotide sequences of the two unknown ORFs (orfII and
orfIII) were very similar to those of P. aeruginosa (99.8%
and 99.7% identity), Acinetobacter genomospecies 3 (99.9%
and 100% identity) and S. marcescens (both 99.7 % identity)
strains previously isolated in Korea, which were arbitrarily
named orfII and orfIII.8 Since several bacterial species
carrying blaVIM-2-containing integrons (which show similarity
in their possession of orfII and orfIII as well as blaVIM-2) have
been isolated in Korea, this may suggest the horizontal spread
of blaVIM-2. As a result of partial DNA sequencing we also
found one Morganella morganii isolate containing an integron
similar to that of E. cloacae KU680.
In conclusion, E. cloacae KU680, which carries a blaVIM-2
gene, represents an emerging threat. The blaVIM-2-containing
integrons are mobile, so horizontal spread of imipenem resist-
ance to more frequent pathogens, such as E. coli, can be antici-
pated. The spread of blaVIM-2 could compromise the future
usefulness of carbapenems for the treatment of infections
caused by Gram-negative bacilli.
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